nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice
|
Schneider-Ohrum, Kirsten |
|
2011 |
29 |
48 |
p. 9081-9092 12 p. |
artikel |
2 |
A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6–14 weeks
|
Sharma, Hitt |
|
2011 |
29 |
48 |
p. 8773-8779 7 p. |
artikel |
3 |
A phase I randomized, double-blind, controlled trial of 2009 influenza A (H1N1) inactivated monovalent vaccines with different adjuvant systems
|
Precioso, Alexander R. |
|
2011 |
29 |
48 |
p. 8974-8981 8 p. |
artikel |
4 |
A systematic review of intradermal influenza vaccines
|
Young, Flora |
|
2011 |
29 |
48 |
p. 8788-8801 14 p. |
artikel |
5 |
Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge
|
Zhang, Minmin |
|
2011 |
29 |
48 |
p. 8943-8950 8 p. |
artikel |
6 |
Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies
|
Pusic, Kae |
|
2011 |
29 |
48 |
p. 8898-8908 11 p. |
artikel |
7 |
Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine
|
Kumar, Manish |
|
2011 |
29 |
48 |
p. 9012-9019 8 p. |
artikel |
8 |
Building on the success of the Expanded Programme on Immunization: Enhancing the focus on disease prevention and control
|
John, T.J. |
|
2011 |
29 |
48 |
p. 8835-8837 3 p. |
artikel |
9 |
Cancer vaccines and carbohydrate epitopes
|
Heimburg-Molinaro, Jamie |
|
2011 |
29 |
48 |
p. 8802-8826 25 p. |
artikel |
10 |
Changes in serotype distribution of Haemophilus influenzae meningitis isolates identified through laboratory-based surveillance following routine childhood vaccination against H. influenzae type b in Brazil
|
Zanella, Rosemeire C. |
|
2011 |
29 |
48 |
p. 8937-8942 6 p. |
artikel |
11 |
Characterization of the interactions of the pneumolysoid, Δ6 PLY, with human neutrophils in vitro
|
Cockeran, R. |
|
2011 |
29 |
48 |
p. 8780-8782 3 p. |
artikel |
12 |
Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination
|
Hanage, W.P. |
|
2011 |
29 |
48 |
p. 8877-8881 5 p. |
artikel |
13 |
Comparing live attenuated and inactivated hepatitis A vaccines: An immunogenicity study after one single dose
|
Zheng, Hui |
|
2011 |
29 |
48 |
p. 9098-9103 6 p. |
artikel |
14 |
Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice
|
Tobias, Joshua |
|
2011 |
29 |
48 |
p. 8863-8869 7 p. |
artikel |
15 |
Development and characterization of chitosan coated poly-(ε-caprolactone) nanoparticulate system for effective immunization against influenza
|
Gupta, Nand Kishore |
|
2011 |
29 |
48 |
p. 9026-9037 12 p. |
artikel |
16 |
Distinct immunoregulatory properties of macrophage migration inhibitory factors encoded by Eimeria parasites and their chicken host
|
Jang, Seung I. |
|
2011 |
29 |
48 |
p. 8998-9004 7 p. |
artikel |
17 |
Do the initial serum level changes of sCD26 have ability to predict successful treatment with IFN-α among naïve chronic hepatitis B patients?
|
Alavi-Moghaddam, Mostafa |
|
2011 |
29 |
48 |
p. 9093-9097 5 p. |
artikel |
18 |
Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece
|
Grivea, Ioanna N. |
|
2011 |
29 |
48 |
p. 8882-8887 6 p. |
artikel |
19 |
Editorial Board/Aims and Scope
|
|
|
2011 |
29 |
48 |
p. CO2- 1 p. |
artikel |
20 |
Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7–59 months. A matched case-control study
|
Domínguez, Angela |
|
2011 |
29 |
48 |
p. 9020-9025 6 p. |
artikel |
21 |
Enhanced immune sera and vaccine: Safe approach to treat scorpion envenoming
|
Lila, Boussag-Abib |
|
2011 |
29 |
48 |
p. 8951-8959 9 p. |
artikel |
22 |
Genetic polymorphisms in host antiviral genes: Associations with humoral and cellular immunity to measles vaccine
|
Haralambieva, Iana H. |
|
2011 |
29 |
48 |
p. 8988-8997 10 p. |
artikel |
23 |
Immunization with the RTS,S/AS malaria vaccine induces IFN-γ +CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge
|
Schwenk, Robert |
|
2011 |
29 |
48 |
p. 8847-8854 8 p. |
artikel |
24 |
Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1–16 years
|
Abarca, Katia |
|
2011 |
29 |
48 |
p. 8855-8862 8 p. |
artikel |
25 |
Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration
|
Cherif, Mahamoud Sama |
|
2011 |
29 |
48 |
p. 9038-9050 13 p. |
artikel |
26 |
Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis
|
Rashid, Imran |
|
2011 |
29 |
48 |
p. 8838-8846 9 p. |
artikel |
27 |
Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India
|
Ali, Mohammad |
|
2011 |
29 |
48 |
p. 9051-9056 6 p. |
artikel |
28 |
Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine
|
Neimert-Andersson, Theresa |
|
2011 |
29 |
48 |
p. 8965-8973 9 p. |
artikel |
29 |
Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation
|
Kumar, Rajnish |
|
2011 |
29 |
48 |
p. 9064-9074 11 p. |
artikel |
30 |
Inflammatory responses to trivalent influenza virus vaccine among pregnant women
|
Christian, Lisa M. |
|
2011 |
29 |
48 |
p. 8982-8987 6 p. |
artikel |
31 |
Influenza associated mortality in the subtropics and tropics: Results from three Asian cities
|
Yang, Lin |
|
2011 |
29 |
48 |
p. 8909-8914 6 p. |
artikel |
32 |
Leishmania major MAP kinase 10 is protective against experimental L. major infection
|
Kumari, Sangeeta |
|
2011 |
29 |
48 |
p. 8783-8787 5 p. |
artikel |
33 |
“Once I begin to participate, people will run away from me”: Understanding stigma as a barrier to HIV vaccine research participation in Kenya
|
Nyblade, Laura |
|
2011 |
29 |
48 |
p. 8924-8928 5 p. |
artikel |
34 |
Perspective of the U.S. Food and Drug Administration on concomitant administration of Zostavax and Pneumovax
|
Baylor, Norman W. |
|
2011 |
29 |
48 |
p. 8771- 1 p. |
artikel |
35 |
Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model
|
Skinner, Julie M. |
|
2011 |
29 |
48 |
p. 8870-8876 7 p. |
artikel |
36 |
Preparing for the next public debate: Universal vaccination against hepatitis B
|
Houweling, Hans |
|
2011 |
29 |
48 |
p. 8960-8964 5 p. |
artikel |
37 |
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection
|
Wang, Dai |
|
2011 |
29 |
48 |
p. 9075-9080 6 p. |
artikel |
38 |
Response to Dr. Norman W. Baylor's Letter to the Editor entitled: “Perspective of the U.S. Food and Drug Administration on Concomitant Administration of Zostavax and Pneumovax”
|
Oxman, Michael N. |
|
2011 |
29 |
48 |
p. 8772- 1 p. |
artikel |
39 |
Rubella vaccines: WHO position paper—Recommendations
|
WHO Publication, |
|
2011 |
29 |
48 |
p. 8767-8768 2 p. |
artikel |
40 |
Safe landing for global polio eradication: A perspective
|
Arita, Isao |
|
2011 |
29 |
48 |
p. 8827-8834 8 p. |
artikel |
41 |
The antitumor immunopreventive effects of a DNA vaccine against CYP26a1 on mouse breast carcinoma
|
Wang, Rong-Chun |
|
2011 |
29 |
48 |
p. 8915-8923 9 p. |
artikel |
42 |
The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands
|
Bogaards, Johannes A. |
|
2011 |
29 |
48 |
p. 8929-8936 8 p. |
artikel |
43 |
The cost-effectiveness of rotavirus vaccination in Armenia
|
Jit, Mark |
|
2011 |
29 |
48 |
p. 9104-9111 8 p. |
artikel |
44 |
The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia
|
Smith, Megan A. |
|
2011 |
29 |
48 |
p. 9112-9122 11 p. |
artikel |
45 |
The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep
|
Maggioli, Gabriela |
|
2011 |
29 |
48 |
p. 9057-9063 7 p. |
artikel |
46 |
Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus
|
Santiago, Felix W. |
|
2011 |
29 |
48 |
p. 8888-8897 10 p. |
artikel |
47 |
Vaccine effectiveness for laboratory-confirmed influenza in children 6–59 months of age, 2005–2007
|
Staat, Mary Allen |
|
2011 |
29 |
48 |
p. 9005-9011 7 p. |
artikel |
48 |
Vaccines against tick-borne encephalitis: WHO position paper – Recommendations
|
WHO Publication, |
|
2011 |
29 |
48 |
p. 8769-8770 2 p. |
artikel |